TANG PRIZE/Tang Prize honors scientists for work to combat diabetes, obesity
06/19/2024 05:17 PM
Three scientists were awarded the 2024 Tang Prize in Biopharmaceutical Science for discovering the Glucagon-like peptide-1 (7-37) (GLP-1 (7-37)) stimulates insulin secretion and can be used in medication combating diabetes and obesity, the Tang Prize Selection Committee announced Wednesday in Taipei.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in TANG PRIZE
- Drugs treating diabetes, obesity can do more: Tang Prize laureatesSvetlana Mojsov and Jens Juul Holst, two of the laureates of the 2024 Tang Prize in Biopharmaceutical Science, said at a forum in Taichung on Tuesday that the GLP-1-based drugs their research spawned could go beyond managing diabetes and obesity.10/01/2024 08:52 PM
- Tang Prize winner lauds Taiwan implementation of human rights covenantsFormer Irish President Mary Robinson on Monday praised Taiwan's efforts to incorporate international covenants on human rights into its domestic law despite not being a signatory.09/30/2024 08:58 PM
- Historian shares research into ancient Chinese myth at Tang Prize forumRenowned Taiwanese-American historian Hsu Cho-yun (許倬雲) on Monday said his work regarding the ancient Chinese myth Da Yu (大禹) was a successful example of integrating social science methodologies into historical research that helped him win the 2024 Tang Prize in Sinology.09/30/2024 01:52 PM
Latest
- Business
EVA Air revenue falls in September, Starlux, Tigerair Taiwan report growth
10/11/2025 06:10 PM - Politics
KMT heavyweight urges Beijing to stay out of party chair race
10/11/2025 05:14 PM - Culture
National Central University names asteroid after Pingtung's Hengchun
10/11/2025 05:01 PM - Business
Stabilization fund to continue market intervention amid U.S. tariff concerns
10/11/2025 04:43 PM - Society
Diver still missing in New Taipei; 3 others rescued: CGA
10/11/2025 04:13 PM